Delivery Order SPE2DB20D3101-SPE2DB25FRLY5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $2,159.74 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Naloxone 2 mg/2 mL syringes. The contract is a firm fixed price delivery order with a completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation, reflecting the vendor's capability to meet federal medical...
- The Defense Logistics Agency awarded a $2,093.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone 0.4 mg/mL in vial format. The contract, which represents no set-aside designation, is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $4,705.66. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competed award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No small business...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4 mg/10 mL vials on July 11, 2025, with a contract ceiling value of $10,276.45. This firm fixed price delivery order, with an ultimate completion date of July 14, 2025, represents a competitively awarded non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Naloxone Hydrochloride, valued at $1,206.73. This firm fixed price delivery order, with an ultimate completion date of September 18, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,928.40 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract is classified as a child award, indicating it derives from a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRLY5Delivery Order
The Defense Logistics Agency awarded a $3,943.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This non-set-aside contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply needs within the Defense Health Agency and broader military healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceuticals, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The naloxone procurement supports emergency medical preparedness capabilities within the Defense Health Agency's pharmaceutical supply chain, consistent with the company's extensive portfolio of medical product deliveries through competitively awarded contracts with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/2/25 |